The nursing care plan contains the direction "observe for refeeding syndrome." The nurse should
closely monitor for complications associated with
a. renal dysfunction.
b. central nervous system dysfunction.
c. endocrine dysfunction.
d. cardiovascular dysfunction.
D
Refeeding resulting in too-rapid weight gain can overwhelm the heart, resulting in cardiovascular
collapse; thus focused assessment becomes a necessity to ensure client physiological integrity. The
other body systems are not initially involved in the refeeding syndrome.
You might also like to view...
An assessment of a 23-year-old patient reveals the following: an auricle that is tender and reddish-blue in color with small vesicles. The nurse would need to know additional information that includes which of these?
a. Any change in the ability to hear b. Any recent drainage from the ear c. Recent history of trauma to the ear d. Any prolonged exposure to extreme cold
A patient admitted for treatment of uncontrolled diabetes mellitus is withdrawn and tearful. The patient says, "I just want to be normal again.". The nurse determines there is a need for a psychiatric evaluation primarily to assist:
a. the patient in verbalizing distress about the disease. b. in assessing the emotional factors affecting the patient's present condition. c. in assessing priorities to be set for the patient's overall nursing plan of care. d. the patient in emotionally accepting the chronic nature of the disease.
A client's maternal serum alpha-fetoprotein (MSAFP. level was unusually elevated at 17 weeks. The nurse suspects which of the following?
A) Fetal hypoxia B) Open spinal defects C) Down syndrome D) Maternal hypertension
The nursing instructor teaches student nurses about the Food and Drug Administration (FDA) Pregnancy Categories. What should the nurse include?
A. Food and Drug Administration (FDA) Pregnancy Category C is safe to use during pregnancy. B. Food and Drug Administration (FDA) Pregnancy categories provide a framework for safe use of drugs in pregnant women. C. Food and Drug Administration (FDA) Pregnancy categories for individual drugs seldom change once they are established. D. Food and Drug Administration (FDA) Pregnancy categories are based on studies using clinical human research trials. E. Food and Drug Administration (FDA) Pregnancy Category X has been associated with teratogenic effects.